Insulin-like growth factor-binding protein-5 (IGFBP-5) is produced by osteoblasts and potentiates
insulin-like growth factor mitogenic stimulation in osteoblast cell cultures.
Progesterone (PG) increased
IGFBP-5 expression in normal human osteoblasts and increased
IGFBP-5 transcription in U2 human
osteosarcoma cells. We developed a
chloramphenicol acetyltransferase reporter construct containing the human
IGFBP-5 proximal promoter sequence, which includes TATA and CAAT boxes, and five putative PG response element half-sites. 10(-8) M PG increased promoter activity of this construct in U2 cells co-transfected with a PG receptor
isoform A (PR(A)) expression vector. Analysis of 5' deletion constructs indicates that PG transactivation of
IGFBP-5 promoter activity does not require the PG response element half-sites but does require the region -162 to -124 containing two tandem CACCC box sequences. Mutation of the proximal CACCC box at -139 eliminated PG transactivation. Gel shift assays using a -162 to -124
DNA fragment, U2 cell nuclear extracts, and purified PR(A)
protein indicate that nuclear factors bind to a CACCC sequence at -139 and that PR(A) alters the pattern of
transcription factor interaction with the CACCC sequence. Using a
luciferase reporter construct containing base pairs -252 to +24 of the
IGFBP-5 promoter, we found that both PR(A) and PR(B)
isoforms mediated PG stimulation of promoter activity. These results suggest that PG may stimulate
IGFBP-5 gene transcription via a novel mechanism involving PR and CACCC-binding factors.